Analysis of the private clinic market in Russia as a result of the takeover of Niarmedic group of companies

UDC 334.758
DOI: 10.51409/v.a.2022.12.04.004

Authors

G. N. Chernukhina,
PhD in Economic sciences, associate Professor, head of the Department of Commerce and trade, Synergy University, Moscow, Russia
M. M. Eldarov,
2nd year master’s student, Financial University under the Government of the Russian Federation” Moscow, Russia

Abstract

The purpose of the work. Large mergers and acquisitions (Merger and Acquisition, M&A) are a trend of recent years. Companies strive for new heights through consolidation, absorption of competitors or purchase of smaller but promising market entities. Choosing the right M&A strategy allows you to achieve many different goals. This is not only an increase in economic indicators, but also a reduction in risks or a withdrawal of business from a difficult situation.
Materials and methods. When writing the article, various research methods were used: analysis, comparison, systematization. Statistical data from the Vademecum business journal on healthcare, as well as data from analytical companies and publications in the media were used to conduct the study.
Results. In the framework of this article, we analyze how the takeover of the Niarmedic Group of companies (hereinafter GC) by Sistema AFC and Sberbank PJSC affected the private clinic market in Russia.
Conclusion. Based on the results of the study, conclusions will be drawn about what the takeover transaction will lead to for the final recipient of the service – the client of the clinics.

Keywords

M&A, merger, acquisition, pharmaceutical sector, private clinics.